Speaker at the ESC Congress 2025.
As of 2025 · Last known relationship
Connecticut Medical Examining Board license (#63934), listed with year 2019.
Daniel Friedman is a Duke University cardiologist and electrophysiology researcher focused on improving complex ablation, pacing, heart-failure care, and non-pharmacologic atrial-fibrillation treatment. He is currently an Associate Professor of Medicine at Duke. His training includes an M.D. from Cornell University (2010), internal medicine residency at Massachusetts General Hospital (2011-2013), and cardiovascular disease (2013-2017) and clinical cardiac electrophysiology (2017-2019) fellowships at Duke. He was an Assistant Professor of Medicine at Yale from 2019 to 2021 and was identified as a Duke cardiology fellow in a 2015 MedicalResearch.com interview. His professional activities have included editorial, reviewing, trial-monitoring, and risk-model work, alongside talks on CRT, heart failure, and atrial-fibrillation ablation.
Listed under 2018-2019 alumni on the Duke fellowship alumni page, with Duke University in the Location column.
Each topic is linked to its supporting source in Sources.
Training includes Speaker at the ESC Congress 2025., Presented “Clinical cases “beyond the guidelines” - The American experience.”, Editorial Board Member of the American Heart Journal., and Assistant Professor of Medicine at Yale University., plus 15 more records.
Explore education and trainingAs of 2025
As of 2022
As of 2021
As of 2021
As of 2021
As of 2021
As of 2020
As of 2019
As of 2019
As of 2019
As of 2019
As of 2018
As of 2017
As of 2017
As of 2013
As of 2010
As of 2006
2030
2026
2023
Research interests include complex ablation, pacemakers and heart failure, cardiac resynchronization therapy, conduction system pacing, atrial fibrillation ablation, left atrial appendage occlusion, and emerging technologies.[6]